Breaking News
Get 50% Off 0
🏄 Grow your portfolio even on vacation with InvestingPro | Summer Sale 50% OFF
CLAIM SALE
Close

Bright Minds Biosciences Inc (DRUG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Bright Minds Biosciences's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
42.5400 +1.9950    +4.92%
14/08 - Closed. Currency in USD
After Hours
42.5500
+0.0100
+0.0235%
0:58:57 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 71,120
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 40.0550 - 44.5000
Bright Minds Biosciences 42.5400 +1.9950 +4.92%

Bright Minds Biosciences Inc Company Profile

 
Get an in-depth profile of Bright Minds Biosciences Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

-

Equity Type

ORD

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatry and neurology indications. Bright Minds Biosciences Inc. has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was founded in 2017 and is headquartered in New York, New York.

Contact Information

Address 19 Vestry Street
New York, 10013
United States
Phone 647 865 8622
Fax -

Top Executives

Name Age Since Title
Jeremy Fryzuk 40 2020 Independent Director
Michael P. Bogenschutz - 2022 Member of Scientific Advisory Board
Robert C. Malenka - 2022 Member of Scientific Advisory Board
Peter Hendricks - 2022 Member of Scientific Advisory Board
Herbert Y. Meltzer - 2022 Member of Scientific Advisory Board
Nils Christian Bottler 37 2020 Independent Director
David M. Weiner 60 2023 Independent Non-Executive Director
Ian McDonald 63 2019 Co-Founder, CEO, President & Director
Jan Torleif Pedersen 60 2022 Chief Science Officer & Director
Terence J. O'Brien - 2025 Member of Scientific Advisory Board
Jacqueline A. French - 2025 Member of Scientific Advisory Board
Joseph E. Sullivan - 2025 Member of Scientific Advisory Board
Dennis J. Dlugos - 2025 Member of Scientific Advisory Board
Jo Sourbron - 2025 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DRUG Comments

Write your thoughts about Bright Minds Biosciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email